Cléa Rosenfeld
Investor Relations Contact chez ONCIMMUNE HOLDINGS PLC
Postes actifs de Cléa Rosenfeld
Sociétés | Poste | Début | Fin |
---|---|---|---|
ONCIMMUNE HOLDINGS PLC | Investor Relations Contact | 01/07/2019 | - |
Historique de carrière de Cléa Rosenfeld
Anciens postes connus de Cléa Rosenfeld
Sociétés | Poste | Début | Fin |
---|---|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Public Communications Contact | - | 23/05/2008 |
SPECTRIS PLC | Investor Relations Contact | - | - |
SHIRE | Public Communications Contact | 27/07/2009 | - |
Statistiques
Internationale
Royaume-Uni | 4 |
Irlande | 2 |
Opérationnelle
Public Communications Contact | 2 |
Investor Relations Contact | 2 |
Sectorielle
Health Technology | 3 |
Commercial Services | 2 |
Producer Manufacturing | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
SPECTRIS PLC | Producer Manufacturing |
ONCIMMUNE HOLDINGS PLC | Health Technology |
Entreprise privées | 2 |
---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Bourse
- Insiders
- Cléa Rosenfeld
- Expérience